GlassScriptPhysician profile
Michelle H Cooper
NPI 1275517922
$3,342.82
in general payments reported to CMS, 2019-2025
33 companies · $452 in 2025
The $452 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $180 · 2021: $268 · 2022: $803 · 2023: $555 · 2024: $688 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347 · Education: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.00 |
| Education | $347.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $599.69 | 2021-2024 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $519.49 | 2021-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $484.24 | 2019-2024 | |
| Exeltis, USA INC. | $161.50 | 2020-2025 | Slynd |
| Myovant Sciences INC. | $160.07 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $154.87 | 2023-2025 | Myfembree |
| Organon LLC | $139.73 | 2022-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $111.68 | 2019-2020 | |
| Exact Sciences Corporation | $106.06 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Millicent US INC | $100.62 | 2019-2024 | Femring, Intrarosa |
| Scynexis, INC. | $94.16 | 2022 | |
| Sage Therapeutics, LLC | $78.74 | 2019-2025 | Zurzuvae |
| Ibsa Pharma INC. | $72.78 | 2021-2024 | Tirosint, Tirosint, Licart |
| Allergan, INC. | $71.70 | 2019-2020 | |
| Therapeuticsmd, INC. | $68.76 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $44.42 | 2024-2025 | Wegovy |
| Abbott Laboratories | $39.47 | 2022 | |
| Merck Sharp & Dohme LLC | $34.46 | 2019-2020 | |
| Pfizer INC. | $31.31 | 2023-2024 | |
| Lilly USA, LLC | $28.42 | 2025 | Mounjaro |
| Boston Scientific Corporation | $27.72 | 2021 | |
| Davol INC. | $23.58 | 2022 | |
| Acella Pharmaceuticals, LLC | $21.46 | 2025 | NP Thyroid 60 |
| Aspira Women'S Health INC | $21.45 | 2023 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $18.97 | 2022 | |
| Coopersurgical, INC. | $17.95 | 2024 | Paragard T 380a |
| Arjo INC. | $17.60 | 2025 | |
| Amgen INC. | $17.55 | 2025 | Evenity |
| Smith+Nephew, INC. | $16.49 | 2025 | Pico 14 |
| Amarin Pharma, INC. | $15.53 | 2019 | |
| Becton, Dickinson and Company | $14.99 | 2021 | |
| Urovant Sciences INC | $13.86 | 2022 | |
| Hologic Sales and Service, LLC | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.